(BGS) B&G Foods - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05508R1068

Frozen Vegetables, Canned Beans, Hot Cereals, Spices, Pickles

BGS EPS (Earnings per Share)

EPS (Earnings per Share) of BGS over the last years for every Quarter: "2020-09": 0.74, "2020-12": 0.35, "2021-03": 0.52, "2021-06": 0.41, "2021-09": 0.55, "2021-12": 0.39, "2022-03": 0.34, "2022-06": 0.07, "2022-09": 0.31, "2022-12": 0.4, "2023-03": 0.27, "2023-06": 0.15, "2023-09": 0.27, "2023-12": 0.3, "2024-03": 0.18, "2024-06": 0.08, "2024-09": 0.13, "2024-12": 0.31, "2025-03": 0.04, "2025-06": 0.04, "2025-09": 0,

BGS Revenue

Revenue of BGS over the last years for every Quarter: 2020-09: 495.759, 2020-12: 510.241, 2021-03: 505.134, 2021-06: 464.375, 2021-09: 514.965, 2021-12: 571.79, 2022-03: 532.407, 2022-06: 478.965, 2022-09: 528.396, 2022-12: 623.232, 2023-03: 511.814, 2023-06: 469.637, 2023-09: 502.734, 2023-12: 578.128, 2024-03: 475.223, 2024-06: 444.59, 2024-09: 461.073, 2024-12: 551.568, 2025-03: 425.402, 2025-06: 424.425, 2025-09: null,

Description: BGS B&G Foods October 26, 2025

B&G Foods Inc. (NYSE:BGS) is a diversified manufacturer and distributor of shelf-stable and frozen foods, as well as household products, operating primarily in the United States, Canada, and Puerto Rico. The company’s portfolio spans over 100 brands-including iconic names such as Green Giant, Cream of Wheat, and Ortega-and covers categories from canned vegetables and cooking oils to hot cereals, sauces, and specialty snacks. Sales are executed both directly and through a broad network of independent brokers, distributors, and retail partners ranging from supermarket chains to warehouse clubs.

Key operating metrics (FY 2023) show revenue of roughly $2.5 billion, an adjusted EBITDA margin near 9 %, and a net income of $115 million, reflecting modest profitability in a low-growth, price-sensitive segment. The packaged foods sector remains vulnerable to inflation-driven input cost volatility (e.g., commodity prices for corn and canola) and shifting consumer preferences toward private-label and healthier options, which compress margins for legacy brands. B&G’s balance sheet carries $1.2 billion of total debt, giving a leverage ratio of about 3.5× EBITDA, a level that warrants monitoring given potential interest-rate headwinds.

If you want a data-rich, forward-looking assessment of BGS-including consensus earnings forecasts, valuation multiples, and scenario-based risk analysis-consider pulling the company’s profile on ValueRay for a deeper dive.

BGS Stock Overview

Market Cap in USD 322m
Sub-Industry Packaged Foods & Meats
IPO / Inception 2007-05-23

BGS Stock Ratings

Growth Rating -82.9%
Fundamental 27.7%
Dividend Rating 19.7%
Return 12m vs S&P 500 -55.3%
Analyst Rating 2.43 of 5

BGS Dividends

Dividend Yield 12m 19.00%
Yield on Cost 5y 4.15%
Annual Growth 5y -20.47%
Payout Consistency 94.0%
Payout Ratio 2.0%

BGS Growth Ratios

Growth Correlation 3m 44.1%
Growth Correlation 12m -66.1%
Growth Correlation 5y -94.2%
CAGR 5y -30.46%
CAGR/Max DD 3y (Calmar Ratio) -0.43
CAGR/Mean DD 3y (Pain Ratio) -0.78
Sharpe Ratio 12m -1.46
Alpha -58.56
Beta 0.470
Volatility 51.30%
Current Volume 1808.5k
Average Volume 20d 2022.4k
Stop Loss 3.7 (-7.5%)
Signal -0.39

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-223.9m TTM) > 0 and > 6% of Revenue (6% = 111.7m TTM)
FCFTA 0.04 (>2.0%) and ΔFCFTA 0.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 26.99% (prev 15.33%; Δ 11.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.05 (>3.0%) and CFO 155.1m > Net Income -223.9m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (79.9m) change vs 12m ago 0.59% (target <= -2.0% for YES)
Gross Margin 21.37% (prev 21.99%; Δ -0.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 59.23% (prev 59.69%; Δ -0.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.92 (EBITDA TTM -55.5m / Interest Expense TTM 155.4m) >= 6 (WARN >= 3)

Altman Z'' 1.58

(A) 0.17 = (Total Current Assets 762.6m - Total Current Liabilities 259.8m) / Total Assets 2.94b
(B) 0.17 = Retained Earnings (Balance) 495.6m / Total Assets 2.94b
(C) -0.05 = EBIT TTM -143.0m / Avg Total Assets 3.14b
(D) 0.21 = Book Value of Equity 501.4m / Total Liabilities 2.44b
Total Rating: 1.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 27.72

1. Piotroski 2.0pt = -3.0
2. FCF Yield 5.41% = 2.71
3. FCF Margin 6.70% = 1.68
4. Debt/Equity 4.06 = -2.08
5. Debt/Ebitda -35.73 = -2.50
6. ROIC - WACC (= -6.52)% = -8.15
7. RoE -39.03% = -2.50
8. Rev. Trend -62.12% = -4.66
9. EPS Trend -75.36% = -3.77

What is the price of BGS shares?

As of November 01, 2025, the stock is trading at USD 4.00 with a total of 1,808,481 shares traded.
Over the past week, the price has changed by -10.51%, over one month by -9.71%, over three months by +1.84% and over the past year by -45.78%.

Is B&G Foods a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, B&G Foods (NYSE:BGS) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 27.72 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BGS is around 3.27 USD . This means that BGS is currently overvalued and has a potential downside of -18.25%.

Is BGS a buy, sell or hold?

B&G Foods has received a consensus analysts rating of 2.43. Therefor, it is recommend to sell BGS.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 5
  • Sell: 0
  • Strong Sell: 2

What are the forecasts/targets for the BGS price?

Issuer Target Up/Down from current
Wallstreet Target Price 4.1 2.5%
Analysts Target Price 4.1 2.5%
ValueRay Target Price 3.5 -13.8%

BGS Fundamental Data Overview October 31, 2025

Market Cap USD = 321.6m (321.6m USD * 1.0 USD.USD)
P/E Forward = 9.1827
P/S = 0.1727
P/B = 0.718
P/EG = 7.93
Beta = 0.47
Revenue TTM = 1.86b USD
EBIT TTM = -143.0m USD
EBITDA TTM = -55.5m USD
Long Term Debt = 1.98b USD (from longTermDebt, last quarter)
Short Term Debt = 37.8m USD (from shortTermDebt, last quarter)
Debt = 2.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 2.31b USD (321.6m + Debt 2.04b - CCE 54.1m)
Interest Coverage Ratio = -0.92 (Ebit TTM -143.0m / Interest Expense TTM 155.4m)
FCF Yield = 5.41% (FCF TTM 124.8m / Enterprise Value 2.31b)
FCF Margin = 6.70% (FCF TTM 124.8m / Revenue TTM 1.86b)
Net Margin = -12.02% (Net Income TTM -223.9m / Revenue TTM 1.86b)
Gross Margin = 21.37% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 20.49% (prev 21.18%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.31b / Total Assets 2.94b)
Interest Expense / Debt = 1.76% (Interest Expense 35.8m / Debt 2.04b)
Taxrate = 22.14% (-2.78m / -12.6m)
NOPAT = -111.3m (EBIT -143.0m * (1 - 22.14%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 762.6m / Total Current Liabilities 259.8m)
Debt / Equity = 4.06 (Debt 2.04b / totalStockholderEquity, last quarter 501.4m)
Debt / EBITDA = -35.73 (negative EBITDA) (Net Debt 1.98b / EBITDA -55.5m)
Debt / FCF = 15.89 (Net Debt 1.98b / FCF TTM 124.8m)
Total Stockholder Equity = 573.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.62% (Net Income -223.9m / Total Assets 2.94b)
RoE = -39.03% (Net Income TTM -223.9m / Total Stockholder Equity 573.7m)
RoCE = -5.59% (EBIT -143.0m / Capital Employed (Equity 573.7m + L.T.Debt 1.98b))
RoIC = -4.29% (negative operating profit) (NOPAT -111.3m / Invested Capital 2.60b)
WACC = 2.24% (E(321.6m)/V(2.36b) * Re(7.75%) + D(2.04b)/V(2.36b) * Rd(1.76%) * (1-Tc(0.22)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.78%
[DCF Debug] Terminal Value 71.32% ; FCFE base≈127.9m ; Y1≈87.2m ; Y5≈43.1m
Fair Price DCF = 10.45 (DCF Value 836.1m / Shares Outstanding 80.0m; 5y FCF grow -37.19% → 3.0% )
EPS Correlation: -75.36 | EPS CAGR: -69.09% | SUE: -2.80 | # QB: 0
Revenue Correlation: -62.12 | Revenue CAGR: -7.66% | SUE: -0.28 | # QB: 0

Additional Sources for BGS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle